MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-UP-50-0001653
Kant Drugs Private Limited
Kant Drugs Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹11.2 Cr
▲ 12% YoY
Net profit · FY 2022
₹77.46 Lakh
Net margin 6.9%
EBITDA · FY 2022
-₹1.01 Cr
EBITDA margin -9%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.15 Cr
Issued & subscribed
Open charges
₹4.24 Cr
Secured borrowings
Company age
25 yrs
Est. 2001
Employees · EPFO
57
Provident fund records
About Kant Drugs Private Limited
Data last updated:
Kant Drugs Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 February 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24232UP2001PTC025855. Its GSTIN is 09AABCK7373E1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.15 Cr. It is led by directors including Vaibhav Rastogi (Managing Director) and Manoj Rastogi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, India – 226003.
As per the financials filed for FY 2022, the company reported a revenue of ₹11.2 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹77.46 Lakh (net margin 6.9%) and EBITDA of -₹1.01 Cr (EBITDA margin -9%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.
The company has about 57 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: S Kant HEALTHCARE. As per MCA filings, the company has open charges of ₹4.24 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 3 cases are pending.
Kant Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0001653). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232UP2001PTC025855
Registration Number 025855
Incorporation Date 05 February 2001
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-50-0001653
Recognitions & Rankings of Kant Drugs
Contact details
Kant Drugs Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBharat Ashramraja Bazar Lucknow, Uttar Pradesh, India – 226003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kant Drugs Private Limited, buy the company report.
Comprehensive company report
Kant Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kant Drugs operates one associated brand: S Kant HEALTHCARE. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical formulations, APIs, conducts research, and exports products worldwide. | skant.com |
Financials of Kant Drugs Private Limited
FY 2025 filings availableKant Drugs Private Limited reported revenue of ₹11.2 Cr (up 12% YoY) for FY 2022.
Revenue · FY 2022
₹11.2 Cr ▲ 12%
Net profit · FY 2022
₹77.46 Lakh margin 6.9%
EBITDA · FY 2022
-₹1.01 Cr margin -9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 11%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 12% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹11.2 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9% | ||||
| Net Profit Margin | 6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kant Drugs Private Limited, buy the company report.
Board of directors of Kant Drugs Private Limited
Kant Drugs has 11 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Rastogi Also directs: Kant Dealers LLP, M.M. Remedies Private Limited, Pharmaris India Private Limited and 1 more | Director | 05 Feb 2001 | 25 Years 8 Months | Current |
| Mehul Rastogi | Director | 22 Sep 2015 | 11 Years 1 Months | Current |
| Anurag Das | Director | 01 Mar 2010 | 16 Years 8 Months | Current |
| Upasana Rastogi Also directs: M.M. Remedies Private Limited | Director | 15 Dec 2025 | 0 Years 10 Months | Current |
| Manjulata Rastogi | Director | 15 Dec 2025 | 0 Years 10 Months | Current |
| Bharati Patwari Rastogi Also directs: M.M. Remedies Private Limited, Das Drugs Private Limited | Director | 18 May 2021 | 5 Years 5 Months | Current |
Showing 6 of 11 current directors. View all directors
Auditor
Kant Drugs Private Limited is audited by KRISHNA RATAN & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNA RATAN & CO | FY 2022 | 005256C |
Shareholding
The shareholding of Kant Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kant Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.24 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Aug 2021 | 100475078 | Hdfc Bank Limited | ₹99 Lakh | Open | |
| 04 Jun 2016 | 100035012 | Hdfc Bank Limited | ₹3.25 Cr | Open |
To see the full charge records of Kant Drugs Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Kant Drugs Private Limited has 5 court cases on record: 3 filed by Kant Drugs, 2 filed against it. 3 cases are pending and 2 are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
3
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 2 | 3 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed by the company against Vijay Laxmi Golden Transport Company THR. Shailendra Dwivedi | Pending |
| District court, Lucknow, Uttar Pradesh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Kannauj, Uttar Pradesh | Court case (M.v. Act) | Filed against the company by State | Disposed |
| District court, Lucknow, Uttar Pradesh | Civil suit | Filed by the company against M/S East India Pharmaceuticals Works Ltd. | Disposed |
To see the full case history of Kant Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kant Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kant Drugs Private Limited has a workforce of 57 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
57
Active EPFO establishments
1
Employee growth
7.55%
GST
Kant Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCK7373E1ZF | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kant Drugs Private Limited, buy the company report.
Recent activity
Kant Drugs Private Limited has 18 board changes on record since 2001: 13 appointments and 5 cessations. The latest: Ekta Rastogi was appointed as Director on 15 Dec 2025.
Appointed
Ekta Rastogi was appointed as Director.
Appointed
Manjulata Rastogi was appointed as Director.
Appointed
Upasana Rastogi was appointed as Director.
AGM
Kant Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Chittaranjan Das ceased to be Director.
Ceased
Tribhuwan Das ceased to be Director.
Filing
Kant Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Hdfc Bank Limited of Rs. 3.25 Cr registered on 04 Jun 2016 with Charge ID 100035012 was modified on 13 Aug 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.99 Cr with Charge ID 100475078 was registered on 27 Aug 2021.
Appointed
Bharati Patwari Rastogi was appointed as Director.
Ceased
Kamini Rastogi ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.25 Cr with Charge ID 100035012 was registered on 04 Jun 2016.
12 earlier events are in the company report.
Frequently asked questions
Kant Drugs is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 February 2001 (25+ years old) and is registered under CIN U24232UP2001PTC025855.
Kant Drugs has 11 current directors:
- Vaibhav Rastogi - Managing Director
- Manoj Rastogi - Director
- Mehul Rastogi - Director
- Anurag Das - Director
- Upasana Rastogi - Director
- Manjulata Rastogi - Director
- Bharati Patwari Rastogi - Director
- Aruna Das - Director
- Ekta Rastogi - Director
- Kusha - Director
- Sandeep Rastogi - Director
The latest financial statements of Kant Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kant Drugs is 09AABCK7373E1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Kant Drugs is U24232UP2001PTC025855. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kant Drugs has 5 court cases on record: 3 filed by the company and 2 filed against it. 3 are pending.
Kant Drugs was incorporated on 05 February 2001, making it 25+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Ekta Rastogi was appointed as Director on 15 Dec 2025. Manjulata Rastogi was appointed as Director on 15 Dec 2025. Upasana Rastogi was appointed as Director on 15 Dec 2025. Kant Drugs has 18 board changes on record in total.
Yes, Kant Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-UP-50-0001653).
The registered office of Kant Drugs is at Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, India – 226003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages